Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas H Groll

Showing results (1-10 of 232) with videos related to

Pageof 24
Sort By:
Early Human Development|February 10, 2011
Efficacy and safety of antifungals in pediatric patientsAndreas H Groll
Current Infectious Disease Reports|October 24, 2008
Invasive opportunistic mycoses: clinical trials review, 2007-2008Andreas H Groll
Deutsches Arzteblatt International|June 2, 2011
Correspondence (letter to the editor): Non-albicans Candida speciesAndreas H Groll
Current Infectious Disease Reports|October 28, 2009
Update on invasive opportunistic mycoses: clinical trials review, 2008-2009Andreas H Groll
Nature Clinical Practice. Oncology|July 25, 2007
Does posaconazole prevent invasive fungal infections in patients with neutropenia?Andreas H Groll
Seminars in Hematology|June 25, 2009
Recent advances in antifungal prevention and treatmentAndreas H Groll, Athanasios Tragiannidis
The Lancet. Child & Adolescent Health|June 18, 2019
Pre-emptive versus empirical antifungal therapy in immunocompromised childrenThomas Lehrnbecher, Andreas H Groll
Mycoses|September 9, 2008
Posaconazole for paediatric patients: status of development and future perspectivesAndreas H Groll, Thomas Lehrnbecher
Journal of the Pediatric Infectious Diseases Society|December 1, 2015
Editorial Commentary: Galactomannan Antigen Testing for Diagnosis of Invasive Aspergillosis in Pediatric Hematology PatientsThomas Lehrnbecher, Andreas H Groll
Mycoses|May 28, 2008
Experiences with the use of caspofungin in paediatric patientsThomas Lehrnbecher, Andreas H Groll
Pageof 24

Showing results (1-10 of 232) with videos related to

Sort By:
Pageof 24
Early Human Development|February 10, 2011
Efficacy and safety of antifungals in pediatric patientsAndreas H Groll
Current Infectious Disease Reports|October 24, 2008
Invasive opportunistic mycoses: clinical trials review, 2007-2008Andreas H Groll
Deutsches Arzteblatt International|June 2, 2011
Correspondence (letter to the editor): Non-albicans Candida speciesAndreas H Groll
Current Infectious Disease Reports|October 28, 2009
Update on invasive opportunistic mycoses: clinical trials review, 2008-2009Andreas H Groll
Nature Clinical Practice. Oncology|July 25, 2007
Does posaconazole prevent invasive fungal infections in patients with neutropenia?Andreas H Groll
Seminars in Hematology|June 25, 2009
Recent advances in antifungal prevention and treatmentAndreas H Groll, Athanasios Tragiannidis
The Lancet. Child & Adolescent Health|June 18, 2019
Pre-emptive versus empirical antifungal therapy in immunocompromised childrenThomas Lehrnbecher, Andreas H Groll
Mycoses|September 9, 2008
Posaconazole for paediatric patients: status of development and future perspectivesAndreas H Groll, Thomas Lehrnbecher
Journal of the Pediatric Infectious Diseases Society|December 1, 2015
Editorial Commentary: Galactomannan Antigen Testing for Diagnosis of Invasive Aspergillosis in Pediatric Hematology PatientsThomas Lehrnbecher, Andreas H Groll
Mycoses|May 28, 2008
Experiences with the use of caspofungin in paediatric patientsThomas Lehrnbecher, Andreas H Groll
Pageof 24